Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.42 |
| ▸ | HTR3A | P46098 | 3/20 | 0.42 |
| ▸ | BTK | Q06187 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24797007 | 1.00 | CA12 (0.43) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19962804 | 0.91 | CA12 (0.49) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19962805 | 0.91 | CA12 (0.49) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19962100 | 0.90 | CA12 (0.46) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19961504 | 0.79 | CA1 (0.56) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19962810 | 0.79 | CA1 (0.56) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL24797189 | 0.78 | CA1 (0.57) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19962098 | 0.78 | CA1 (0.57) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19961511 | 0.78 | CA1 (0.57) | CA12CA1CA2CA9FKBP1A | |
| SCHEMBL19961993 | 0.71 | CA1 (0.54) | CA12CA1CA2CA9FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230133705-A1 | TREHALOSE ANALOGUES | CENTRAL MICHIGAN UNIVERSITY | 2023-05-04 | — | — | US | disclosed |
| US-11535642-B2 | Trehalose analogues | CENTRAL MICHIGAN UNIVERSITY (US) | 2022-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133705-A1 | TREHALOSE ANALOGUES | TREH, TALDO1, GALE | CA12 1817/4885CA1 2754/4885CA2 3388/4885 |
| US-11535642-B2 | Trehalose analogues | TREH, TALDO1, GALE | CA12 1817/4885CA1 2754/4885CA2 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.